As Senior Director, Health Outcomes at Prime Therapeutics, Dr. Gleason leads Prime’s clinical health outcomes assessment team in the development and improvement of pharmacy benefit management programs. Through integrated medical and pharmacy claims data analysis, Dr. Gleason assesses clinical program opportunity and post-implementation outcomes.

Dr. Gleason is an Adjunct Professor of Pharmacy at the University of Minnesota, College of Pharmacy. He is a Board Certified Pharmacotherapy Specialist (BCPS), an elected Fellow of the Academy of Managed Care Pharmacy (FAMCP), as well as an the American College of Clinical Pharmacy (FCCP). Dr. Gleason currently serves on the Academy of Managed Care Pharmacy, Board of Directors.

He has over 40 peer-reviewed publications in medical and health policy journals such as Health Affairs, Journal of Managed Care Pharmacy (JMCP), Medical Care, Archives of Internal Medicine, and JAMA.

Dr. Gleason completed his Bachelor of Science and Pharmacy Doctorate degrees at the University of Minnesota. Gleason also completed an Ambulatory Care Pharmacy Practice Residency at the University of Pittsburgh Medical Center followed by a Fellowship in Outcomes Research through the University of Pittsburgh, School of Pharmacy.